Speaker - Barry Bunin

 Barry  Bunin  Thumbnail


Dr. Barry Bunin, CEO & President of Collaborative Drug Discovery Inc. ( helps scientists in secure collaborative groups more rapidly develop drug candidates for commercial and humanitarian markets. Thousands of researchers worldwide use CDD today. Dr. Bunin and CDD received funding in 2008 to support a global community of leading TB researchers from the Gates Foundation (BMGF). He co- authored “Chemoinformatics: Theory, Practice, and Products”, a text that overviews modern chemoinformatics technologies and “The Combinatorial Index”, a widely used text on high- throughput chemical synthesis. Dr. Bunin was an Entrepreneur-in-Residence at Eli Lilly and the founding CEO, President, & CSO of Libraria. In the lab, Dr. Bunin did medicinal chemistry developing patented new chemotypes for protease inhibition at Axys Pharmaceuticals and RGD mimics to inhibit GP-IIbIIIa at Genentech. Dr. Bunin is on a patent for Carfilzomib – a selective proteasome inhibitor now in phase 3 clinical trials for multiple myeloma. Dr. Bunin received his

Ph.D. at Berkeley, where he synthesized and tested the initial 1,4-benzodiazepine libraries with Professor Jonathan Ellman.

2 Programs

Collaborative Innovation in Biopharma Research

10.20.12 | 01:08:12 min | 0 comments

Bunin, Hessel, Izant: Open Source Drug Discovery

07.31.10 | 01:29:29 min | 0 comments